Effectiveness of early diagnosis, prevention, and treatment of Clostridium difficile infection

Butler M, Bliss D, Drekonja D, Filice G, Rector T, MacDonald R, Wilt T. Effectiveness of Early Diagnosis, Prevention, and Treatment of Clostridium difficile Infection. Comparative Effectiveness Review No. 31 (Prepared by the Minnesota Evidence-based Practice Center under Contract No. 290-02-0009.) AHRQ Publication No. 11(12)-EHC051-EF. Rockville, MD. Agency for Healthcare Research and Quality. December 2011.

[1]  S. Michie,et al.  Interventions to improve antibiotic prescribing practices for hospital inpatients. , 2017, The Cochrane database of systematic reviews.

[2]  Pamela Sears,et al.  Fidaxomicin versus vancomycin for Clostridium difficile infection. , 2011, The New England journal of medicine.

[3]  A. Robicsek,et al.  Significant impact of terminal room cleaning with bleach on reducing nosocomial Clostridium difficile. , 2010, American journal of infection control.

[4]  M. Howell,et al.  Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. , 2010, Archives of internal medicine.

[5]  Amy Linsky,et al.  Proton pump inhibitors and risk for recurrent Clostridium difficile infection. , 2010, Archives of internal medicine.

[6]  Roger Baxter,et al.  Treatment with monoclonal antibodies against Clostridium difficile toxins. , 2010, The New England journal of medicine.

[7]  E. Marlowe,et al.  Clostridium difficile Testing in the Clinical Laboratory by Use of Multiple Testing Algorithms , 2010, Journal of Clinical Microbiology.

[8]  E. Bouza,et al.  Comparison of ImmunoCard Toxins A&B and the New Semiautomated Vidas Clostridium difficile Toxin A&B Tests for Diagnosis of C. difficile Infection , 2010, Journal of Clinical Microbiology.

[9]  B. Oppenheim,et al.  Evaluation of Diagnostic Tests for Clostridium difficile Infection , 2009, Journal of Clinical Microbiology.

[10]  O. Dekkers,et al.  European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[11]  A. Goorhuis,et al.  Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the Netherlands. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[12]  M. Landry,et al.  Comparison of BD GeneOhm Cdiff Real-Time PCR Assay with a Two-Step Algorithm and a Toxin A/B Enzyme-Linked Immunosorbent Assay for Diagnosis of Toxigenic Clostridium difficile Infection , 2009, Journal of Clinical Microbiology.

[13]  L. Peterson,et al.  Molecular epidemiology of Clostridium difficile over the course of 10 years in a tertiary care hospital. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  A. Bader,et al.  Proposed Checklist of Hospital Interventions to Decrease the Incidence of Healthcare-Associated Clostridium difficile Infection , 2009, Infection Control & Hospital Epidemiology.

[15]  A. Charlett,et al.  Comparison of Nine Commercially Available Clostridium difficile Toxin Detection Assays, a Real-Time PCR Assay for C. difficile tcdB, and a Glutamate Dehydrogenase Detection Assay to Cytotoxin Testing and Cytotoxigenic Culture Methods , 2009, Journal of Clinical Microbiology.

[16]  R. Chinn,et al.  National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. , 2009, American journal of infection control.

[17]  Mark Miller,et al.  Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  K. Kaier,et al.  Two Time-Series Analyses of the Impact of Antibiotic Consumption and Alcohol-Based Hand Disinfection on the Incidences of Nosocomial Methicillin-Resistant Staphylococcus aureus Infection and Clostridium difficile Infection , 2009, Infection Control & Hospital Epidemiology.

[19]  D. Musher,et al.  Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  L. Mcfarland.  Renewed interest in a difficult disease: Clostridium difficile infections – epidemiology and current treatment strategies , 2009, Current opinion in gastroenterology.

[21]  Richard Holliman,et al.  Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. , 2008, The Lancet. Infectious diseases.

[22]  K. Garey,et al.  Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. , 2008, The Journal of hospital infection.

[23]  S. Coffin,et al.  Epidemiological Features of Clostridium difficile-Associated Disease Among Inpatients at Children's Hospitals in the United States, 2001–2006 , 2008, Pediatrics.

[24]  E. Bouza,et al.  Comparison of Three Commercial Methods for Rapid Detection of Clostridium difficile Toxins A and B from Fecal Specimens , 2008, Journal of Clinical Microbiology.

[25]  J. Schrenzel,et al.  Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile. , 2008, The Journal of antimicrobial chemotherapy.

[26]  R. Cunningham,et al.  Is over-use of proton pump inhibitors fuelling the current epidemic of Clostridium difficile-associated diarrhoea? , 2008, The Journal of hospital infection.

[27]  M. Aseeri,et al.  Gastric Acid Suppression by Proton Pump Inhibitors as a Risk Factor for Clostridium Difficile-Associated Diarrhea in Hospitalized Patients , 2008, The American Journal of Gastroenterology.

[28]  John M Boyce,et al.  Impact of Hydrogen Peroxide Vapor Room Decontamination on Clostridium difficile Environmental Contamination and Transmission in a Healthcare Setting , 2008, Infection Control & Hospital Epidemiology.

[29]  Z. Samra,et al.  Evaluation of Two Rapid Immunochromatography Tests for the Detection of Clostridium difficile Toxins , 2008, Digestive Diseases and Sciences.

[30]  J. Rosenblatt,et al.  Comparison of Real-Time PCR for Detection of the tcdC Gene with Four Toxin Immunoassays and Culture in Diagnosis of Clostridium difficile Infection , 2008, Journal of Clinical Microbiology.

[31]  D. Antonopoulos,et al.  Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. , 2008, The Journal of infectious diseases.

[32]  Carlene A. Muto,et al.  Measures to control and prevent Clostridium difficile infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  Valerie Smith,et al.  Prospective, Controlled, Cross-Over Trial of Alcohol-Based Hand Gel in Critical Care Units , 2008, Infection Control & Hospital Epidemiology.

[34]  V. Anttila,et al.  A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: Efficacy and safety data of a prematurely interrupted trial , 2008, Scandinavian journal of infectious diseases.

[35]  L. McDonald.  Confronting Clostridium difficile in inpatient health care facilities. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  L. Valiquette,et al.  Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  Melinda B Davis,et al.  A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  C. Bulpitt,et al.  Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial , 2007, BMJ : British Medical Journal.

[39]  M. Hannan,et al.  Emergence and Control of Fluoroquinolone-Resistant, Toxin A–Negative, Toxin B–Positive Clostridium difficile , 2007, Infection Control & Hospital Epidemiology.

[40]  Pranav Jain,et al.  Detection of Clostridium difficile Toxin: Comparison of Enzyme Immunoassay Results with Results Obtained by Cytotoxicity Assay , 2007, Journal of Clinical Microbiology.

[41]  Jacqueline Whitaker,et al.  Designing a protocol that eliminates Clostridium difficile: a collaborative venture. , 2007, American journal of infection control.

[42]  John K Marshall,et al.  Systematic Review of the Risk of Enteric Infection in Patients Taking Acid Suppression , 2007, The American Journal of Gastroenterology.

[43]  B S Cooper,et al.  Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series. , 2007, The Journal of antimicrobial chemotherapy.

[44]  R. Branch,et al.  Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea. , 2007, American journal of infection control.

[45]  Jeanne E. Zack,et al.  Use of Hypochlorite Solution to Decrease Rates of Clostridium difficile-Associated Diarrhea , 2007, Infection Control & Hospital Epidemiology.

[46]  Christine H. Lee,et al.  Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile-associated diarrhea. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  D. Musher,et al.  Nitazoxanide for the treatment of Clostridium difficile colitis. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[48]  J. Zenilman,et al.  Burden of Clostridium Difficile‐Associated Diarrhea in a Long‐Term Care Facility , 2006, Journal of the American Geriatrics Society.

[49]  D. Musher,et al.  An update on diagnosis, treatment, and prevention of Clostridium difficile-associated disease. , 2006, Gastroenterology clinics of North America.

[50]  B. Beşirbellioğlu,et al.  Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study. , 2006, Medical science monitor : international medical journal of experimental and clinical research.

[51]  A. Barkun,et al.  Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. , 2005, JAMA.

[52]  Ken Dewar,et al.  A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. , 2005, The New England journal of medicine.

[53]  F. Gordin,et al.  Reduction in Nosocomial Transmission of Drug-Resistant Bacteria After Introduction of an Alcohol-Based Handrub , 2005, Infection Control & Hospital Epidemiology.

[54]  Patricia Muñoz,et al.  Saccharomyces cerevisiae fungemia: an emerging infectious disease. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[55]  S. Lewis,et al.  Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[56]  A. Awasthi,et al.  Failure of dietary oligofructose to prevent antibiotic‐associated diarrhoea , 2005, Alimentary pharmacology & therapeutics.

[57]  A. Huang,et al.  Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case–control studies , 2004, Canadian Medical Association Journal.

[58]  D. O’Mahony,et al.  Antibiotic prescribing policy and Clostridium difficile diarrhoea. , 2004, QJM : monthly journal of the Association of Physicians.

[59]  M. Wilcox,et al.  Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea. , 2004, The Journal of antimicrobial chemotherapy.

[60]  Vincent B. Young,et al.  Antibiotic-Associated Diarrhea Accompanied by Large-Scale Alterations in the Composition of the Fecal Microbiota , 2004, Journal of Clinical Microbiology.

[61]  M. Weaver,et al.  Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. , 2004, International microbiology : the official journal of the Spanish Society for Microbiology.

[62]  A. Limaye,et al.  Six Rapid Tests for Direct Detection of Clostridium difficile and Its Toxins in Fecal Samples Compared with the Fibroblast Cytotoxicity Assay , 2003, Journal of Clinical Microbiology.

[63]  X. Hébuterne.  Gut changes attributed to ageing: effects on intestinal microflora , 2003, Current opinion in clinical nutrition and metabolic care.

[64]  I. Odenholt,et al.  Lactobacillus plantarum 299v for the Treatment of Recurrent Clostridium difficile-associated Diarrhoea: A Double-blind, Placebo-controlled Trial , 2003, Scandinavian journal of infectious diseases.

[65]  M. Loeb,et al.  Infection Control and Hospital Epidemiology Clostridium Difficile in Long-term–care Facilities for the Elderly Shea Position Paper , 2022 .

[66]  Matthew R. Thomas,et al.  Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial. , 2001, Mayo Clinic proceedings.

[67]  M. Cormican,et al.  Evaluation of Methods for Detection of Toxins in Specimens of Feces Submitted for Diagnosis of Clostridium difficile- Associated Diarrhea , 2001, Journal of Clinical Microbiology.

[68]  D. Pardi,et al.  Clostridium difficile-associated diarrhea and colitis. , 2001, Mayo Clinic proceedings.

[69]  L. Brandt,et al.  Treatment of recurrent Clostridium difficile–associated diarrhea by administration of donated stool directly through a colonoscope , 2000, American Journal of Gastroenterology.

[70]  T. Leet,et al.  Environmental control to reduce transmission of Clostridium difficile. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[71]  C. Surawicz,et al.  The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[72]  N. Brown,et al.  An antibiotic policy associated with reduced risk of Clostridium difficile-associated diarrhoea. , 1999, Age and ageing.

[73]  Pallasch Tj.  Clostridium difficile-associated diarrhea and colitis. , 1999 .

[74]  P. Mennonna,et al.  Effectiveness of infection control program in controlling nosocomial Clostridium difficile. , 1998, American journal of infection control.

[75]  G E Bignardi,et al.  Risk factors for Clostridium difficile infection. , 1998, The Journal of hospital infection.

[76]  J. Jernigan,et al.  A Randomized Crossover Study of Disposable Thermometers for Prevention of Clostridium difficile and Other Nosocomial Infections , 1998, Infection Control & Hospital Epidemiology.

[77]  N. Schupf,et al.  Reduction in Vancomycin-Resistant Enterococcus and Clostridium Difficile Infections Following Change to Tympanic Thermometers , 1998, Infection Control & Hospital Epidemiology.

[78]  R. E. Barry,et al.  The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients. , 1998, The Journal of infection.

[79]  M. Samore,et al.  Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea , 1998, The Lancet.

[80]  R N Baldwin,et al.  Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy. , 1997, The Journal of antimicrobial chemotherapy.

[81]  W. Graninger,et al.  Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[82]  C. Surawicz,et al.  A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. , 1994, JAMA.

[83]  D. McCann,et al.  Management and control of a large outbreak of diarrhoea due to Clostridium difficile. , 1994, The Journal of hospital infection.

[84]  D. Gerding,et al.  Decrease in Nosocomial Clostridium difficileAssociated Diarrhea by Restricting Clindamycin Use , 1994, Annals of Internal Medicine.

[85]  M. Samore,et al.  Clostridium difficile colonization and diarrhea at a tertiary care hospital. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[86]  N. Schupf,et al.  Reduction in the incidence of Clostridium difficile-associated diarrhea in an acute care hospital and a skilled nursing facility following replacement of electronic thermometers with single-use disposables. , 1992, Infection control and hospital epidemiology.

[87]  M. Delmée,et al.  Control of nosocomial transmission of Clostridium difficile based on sporadic case surveillance. , 1991, The American journal of medicine.

[88]  Mark A. Miller,et al.  Risk Factors for the Development of Clostridium difficile-Associated Diarrhea During a Hospital Outbreak , 1991, Infection Control & Hospital Epidemiology.

[89]  G. Talbot,et al.  Risk factors for Clostridium difficile toxin-associated diarrhea. , 1990, Infection control and hospital epidemiology.

[90]  J. Hotz.  [Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study]. , 1990, Zeitschrift fur Gastroenterologie.

[91]  L. Peterson,et al.  Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. , 1990, The American journal of medicine.

[92]  J. Rask-Madsen,et al.  BACTERIOTHERAPY FOR CHRONIC RELAPSING CLOSTRIDIUM DIFFICILE DIARRHOEA IN SIX PATIENTS , 1989, The Lancet.

[93]  W. Stamm,et al.  Nosocomial acquisition of Clostridium difficile infection. , 1989, The New England journal of medicine.

[94]  K. Wilson,et al.  Acquisition of Clostridium difficile from the hospital environment. , 1988, American journal of epidemiology.

[95]  M. Dudley,et al.  Oral bacitracin vs vancomycin therapy for Clostridium difficile-induced diarrhea. A randomized double-blind trial. , 1986, Archives of internal medicine.

[96]  D. Gerding,et al.  PROSPECTIVE RANDOMISED TRIAL OF METRONIDAZOLE VERSUS VANCOMYCIN FOR CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHOEA AND COLITIS , 1983, The Lancet.

[97]  D. Youngs,et al.  Randomized controlled trial of colestipol in antibiotic‐associated colitis , 1982, The British journal of surgery.

[98]  M. Keighley,et al.  Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea. , 1978, British medical journal.

[99]  B. Jaar,et al.  Intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis: an observational study and review of the literature. , 2010, Journal of hospital medicine.

[100]  E. Renshaw,et al.  Spatio-temporal stochastic modelling of Clostridium difficile. , 2009, The Journal of hospital infection.

[101]  O. Vandenberg,et al.  Diagnostic value of five commercial tests for the rapid diagnosis of Clostridium difficile-associated disease. , 2008, Clinical laboratory.

[102]  R. Nelson,et al.  Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. , 2007, The Cochrane database of systematic reviews.

[103]  E. Kuijper,et al.  Evaluation of real-time PCR and conventional diagnostic methods for the detection of Clostridium difficile-associated diarrhoea in a prospective multicentre study. , 2007, Journal of medical microbiology.

[104]  J. Gerberding,et al.  Severe Clostridium difficile-associated disease in populations previously at low risk--four states, 2005. , 2005, MMWR. Morbidity and mortality weekly report.

[105]  L. Brandt,et al.  Clostridium difficile-associated diarrhea in the elderly , 1999, American Journal of Gastroenterology.

[106]  M. Samore,et al.  Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. , 1996, The American journal of medicine.

[107]  B. Aronsson,et al.  Medical implications of nosocomial infection with Clostridium difficile. , 1989, Scandinavian journal of infectious diseases.

[108]  J. Silva,et al.  Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens. , 1989, The American journal of medicine.

[109]  J. Bartlett,et al.  Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. , 1981, Gastroenterology.

[110]  J. Silva,et al.  Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. , 1981, The Journal of infectious diseases.